长风药业(02652)建议采纳H股奖励计划

Core Viewpoint - Changfeng Pharmaceutical (02652) has announced a proposal to adopt a H-share incentive trust plan on November 12, 2025, aimed at aligning the interests of employees, management, and shareholders, while attracting, retaining, and incentivizing key talents to drive the company's sustainable development and long-term success [1] Group 1 - The H-share incentive plan is designed to align the interests of employees, management, and shareholders [1] - The plan aims to attract, retain, and incentivize key talents within the company [1] - The initiative is expected to contribute to the company's sustainable development and long-term success [1]